MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Biochemistry

Background:

• Chronic obstructive pulmonary disease (COPD) involves progressive airflow limitation and chronic inflammation.
• Matrix metalloproteinases (MMPs) and neutrophil elastase (NE) are implicated in COPD, but their regulation is not fully understood.
• MicroRNA-139-5p may play a role in regulating MMPs in COPD.

Purpose of the Study:

• To compare levels of MMP-8, MMP-9, and NE in peripheral blood and exhaled breath condensate (EBC) of COPD patients and controls.
• To assess the expression of miRNA-139-5p in peripheral blood mononuclear cells (PBMCs) of COPD patients.
• To investigate the relationship between these markers, disease severity, and exacerbations.

Main Methods:

• Collected blood and EBC from stable COPD patients, COPD patients during exacerbations, and healthy controls.
• Measured mRNA expression of MMP-8, MMP-9, NE, and miRNA-139-5p in PBMCs using qRT-PCR.
• Quantified MMP-8, MMP-9, and NE protein in plasma and MMP-8, MMP-9 protein in EBC using enzyme-linked immunoassays.

Main Results:

• COPD patients exhibited significantly higher mRNA expression for MMP-8, MMP-9, and NE in PBMCs compared to controls.
• NE mRNA expression was higher during COPD exacerbations than in stable COPD.
• mRNA expression of MMP-9 and NE correlated negatively with spirometry results in COPD patients.
• Plasma levels of MMP-8, MMP-9, and NE proteins were elevated in COPD patients.
• MMP-8 protein levels were lower in the EBC of COPD patients.

Conclusions:

• Enhanced mRNA expression of MMP-9 and NE in PBMCs is associated with COPD.
• These elevated markers may correlate with COPD disease severity and exacerbations.
• Further research into miRNA-139-5p regulation of MMPs could provide therapeutic targets for COPD.